These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 29752726)
1. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target. Ma S; Paiboonrungruan C; Yan T; Williams KP; Major MB; Chen XL Ann N Y Acad Sci; 2018 Dec; 1434(1):164-172. PubMed ID: 29752726 [TBL] [Abstract][Full Text] [Related]
2. The expression of p-p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance. Wang Z; Zhang J; Li M; Kong L; Yu J Thorac Cancer; 2020 Jan; 11(1):130-139. PubMed ID: 31755241 [TBL] [Abstract][Full Text] [Related]
3. Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells. Liu M; Hu C; Xu Q; Chen L; Ma K; Xu N; Zhu H Biosci Rep; 2015 Sep; 35(5):. PubMed ID: 26341629 [TBL] [Abstract][Full Text] [Related]
4. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy. Zhang J; Jiao Q; Kong L; Yu J; Fang A; Li M; Yu J Thorac Cancer; 2018 Jun; 9(6):726-735. PubMed ID: 29675925 [TBL] [Abstract][Full Text] [Related]
5. Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus. Fu J; Xiong Z; Huang C; Li J; Yang W; Han Y; Paiboonrungruan C; Major MB; Chen KN; Kang X; Chen X J Biol Chem; 2019 Jan; 294(1):327-340. PubMed ID: 30409900 [TBL] [Abstract][Full Text] [Related]
6. NRF2/ACSS2 axis mediates the metabolic effect of alcohol drinking on esophageal squamous cell carcinoma. Odera JO; Xiong Z; Huang C; Gu N; Yang W; Githang'a J; Odera E; Paiboonrungruang C; Chen X Biochem J; 2020 Aug; 477(16):3075-3089. PubMed ID: 32776152 [TBL] [Abstract][Full Text] [Related]
7. Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma. Li MY; Fan LN; Han DH; Yu Z; Ma J; Liu YX; Li PF; Zhao DH; Chai J; Jiang L; Li SL; Xiao JJ; Duan QH; Ye J; Shi M; Nie YZ; Wu KC; Liao DJ; Shi Y; Wang Y; Yan QG; Guo SP; Bian XW; Zhu F; Zhang J; Wang Z J Clin Invest; 2020 Aug; 130(8):4301-4319. PubMed ID: 32396532 [TBL] [Abstract][Full Text] [Related]
8. Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma. Hsieh CH; Kuan WH; Chang WL; Kuo IY; Liu H; Shieh DB; Liu H; Tan B; Wang YC J Biomed Sci; 2022 Oct; 29(1):90. PubMed ID: 36310172 [TBL] [Abstract][Full Text] [Related]
9. Differential squamous cell fates elicited by NRF2 gain of function versus KEAP1 loss of function. Takahashi J; Suzuki T; Sato M; Nitta S; Yaguchi N; Muta T; Tsuchida K; Suda H; Morita M; Hamada S; Masamune A; Takahashi S; Kamei T; Yamamoto M Cell Rep; 2024 Apr; 43(4):114104. PubMed ID: 38602872 [TBL] [Abstract][Full Text] [Related]
10. miR-145 Regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L. Chen Q; Hou J; Wu Z; Zhao J; Ma D Pathol Res Pract; 2019 Jul; 215(7):152427. PubMed ID: 31072625 [TBL] [Abstract][Full Text] [Related]
11. Development of targeted therapy of NRF2 Paiboonrungruang C; Simpson E; Xiong Z; Huang C; Li J; Li Y; Chen X Cell Signal; 2021 Oct; 86():110105. PubMed ID: 34358647 [TBL] [Abstract][Full Text] [Related]
12. Small molecule screen identifies pyrimethamine as an inhibitor of NRF2-driven esophageal hyperplasia. Paiboonrungruang C; Xiong Z; Lamson D; Li Y; Bowman B; Chembo J; Huang C; Li J; Livingston EW; Frank JE; Chen V; Li Y; Weissman B; Yuan H; Williams KP; Ben Major M; Chen X Redox Biol; 2023 Nov; 67():102901. PubMed ID: 37776708 [TBL] [Abstract][Full Text] [Related]
13. Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment. Shen H; Yang Y; Xia S; Rao B; Zhang J; Wang J Dis Esophagus; 2014; 27(7):685-92. PubMed ID: 24028437 [TBL] [Abstract][Full Text] [Related]
14. LncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2. Zhang Z; Xiong R; Li C; Xu M; Guo M Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):826-833. PubMed ID: 31287493 [TBL] [Abstract][Full Text] [Related]
15. NOTCH and Esophageal Squamous Cell Carcinoma. Li Y; Li Y; Chen X Adv Exp Med Biol; 2021; 1287():59-68. PubMed ID: 33034026 [TBL] [Abstract][Full Text] [Related]
16. Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma. He X; Zhou Y; Chen W; Zhao X; Duan L; Zhou H; Li M; Yu Y; Zhao J; Guo Y; Gu H; Jiang Y; Dong Z; Liu K Oncogene; 2023 Apr; 42(15):1209-1223. PubMed ID: 36841865 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of Nrf2/HO-1 expression and its correlation with occurrence in esophageal squamous cell carcinoma. Gao Y; Li M; Wang B; Ma Y Genes Genomics; 2023 Jun; 45(6):723-739. PubMed ID: 37043130 [TBL] [Abstract][Full Text] [Related]
18. The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma. Zhao Y; Zhu J; Shi B; Wang X; Lu Q; Li C; Chen H J Exp Clin Cancer Res; 2019 Jul; 38(1):304. PubMed ID: 31296250 [TBL] [Abstract][Full Text] [Related]
19. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway. Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989 [TBL] [Abstract][Full Text] [Related]
20. Decreased Expression of NRF2 Target Genes after Alcohol Exposure in the Background Esophageal Mucosa of Patients with Esophageal Squamous Cell Carcinoma. Toda S; Hatta W; Asanuma K; Asano N; Ono Y; Abe H; Ogata Y; Saito M; Kanno T; Jin X; Uno K; Koike T; Imatani A; Hamada S; Nakamura T; Nakaya N; Masamune A Tohoku J Exp Med; 2022 Oct; 258(3):195-206. PubMed ID: 36070895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]